Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHODH | Q02127 | 15/20 | 0.74 |
| ▸ | GSTO1 | P78417 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | ATP4A | P20648 | 1/20 | 0.45 |
| ▸ | ATP4B | P51164 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28794001 | 1.00 | DHODH (0.74) | DHODHGSTO1LMNAALDH1A1KMT2A | |
| SCHEMBL20956575 | 0.87 | DHODH (0.67) | DHODHGSTO1KMT2AATP4AATP4B | |
| SCHEMBL20956573 | 0.87 | DHODH (0.67) | DHODHGSTO1KMT2AATP4AATP4B | |
| SCHEMBL29911563 | 0.85 | DHODH (1.00) | DHODHGSTO1ALDH1A1 | |
| SCHEMBL19631365 | 0.85 | DHODH (1.00) | DHODHGSTO1ALDH1A1 | |
| SCHEMBL20956565 | 0.85 | DHODH (1.00) | DHODHGSTO1ALDH1A1 | |
| SCHEMBL19631432 | 0.80 | DHODH (0.78) | DHODHGSTO1 | |
| SCHEMBL19631360 | 0.78 | DHODH (0.78) | DHODHALDH1A1 | |
| SCHEMBL19631361 | 0.78 | DHODH (0.78) | DHODHGSTO1 | |
| SCHEMBL25614262 | 0.78 | DHODH (0.53) | DHODHLMNAALDH1A1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230190713-A1 | ANTI-RNA VIRUS DRUG AND APPLICATION THEREOF | EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2023-06-22 | — | — | US | disclosed |
| US-11590109-B2 | Applications of novel thiazole derivative in treating virus infection | INSTITUT PASTEUR OF SHANGHAI, CHINESE ACADEMY OF SCIENCES (CN) | 2023-02-28 | — | — | US | disclosed |
| EP-4116296-A1 | ANTI-RNA VIRUS DRUG AND APPLICATION THEREOF | East China University of Science and Technology (CN) | 2023-01-11 | — | — | EP | disclosed |
| US-11534427-B2 | Applications of novel thiazole derivative in treating inflammatory bowel diseases | EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2022-12-27 | — | — | US | disclosed |
| CN-107375279-B | Use of novel thiazole derivatives for the treatment of inflammatory bowel disease | 华东理工大学 | 2022-11-01 | — | — | CN | disclosed |
| CN-107459496-B | Use of thiazole derivatives for treating viral infections | 华东理工大学 | 2022-07-19 | — | — | CN | disclosed |
| US-20190290620-A1 | APPLICATIONS OF NOVEL THIAZOLE DERIVATIVE IN TREATING INFLAMMATORY BOWEL DISEASES | EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2019-09-26 | — | — | US | disclosed |
| US-20190134008-A1 | APPLICATIONS OF NOVEL THIAZOLE DERIVATIVE IN TREATING VIRUS INFECTION | EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2019-05-09 | — | — | US | disclosed |
| WO-2017206955-A1 | APPLICATIONS OF NOVEL THIAZOLE DERIVATIVE IN TREATING VIRUS INFECTION | 华东理工大学 | 2017-12-07 | — | — | WO | disclosed |
| WO-2017198179-A1 | APPLICATIONS OF NOVEL THIAZOLE DERIVATIVE IN TREATING INFLAMMATORY BOWEL DISEASES | 华东理工大学 | 2017-11-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11534427-B2 | Applications of novel thiazole derivative in treating inflammatory bowel diseases | FABP2, SLC10A2, ALPI | DHODH 803/4885GSTO1 2825/4885LMNA 4787/4885 |
| US-20190290620-A1 | APPLICATIONS OF NOVEL THIAZOLE DERIVATIVE IN TREATING INFLAMMATORY BOWEL DISEASES | FABP2, SLC10A2, ALPI | DHODH 803/4885GSTO1 2825/4885LMNA 4787/4885 |
| US-11590109-B2 | Applications of novel thiazole derivative in treating virus infection | HAVCR2, MAVS, EIF2AK2 | DHODH 1507/4885GSTO1 4096/4885LMNA 4607/4885 |
| US-20190134008-A1 | APPLICATIONS OF NOVEL THIAZOLE DERIVATIVE IN TREATING VIRUS INFECTION | HAVCR2, MAVS, EIF2AK2 | DHODH 1507/4885GSTO1 4096/4885LMNA 4607/4885 |
| US-20230190713-A1 | ANTI-RNA VIRUS DRUG AND APPLICATION THEREOF | SARS1, EIF2AK2, NSUN3 | DHODH 2268/4885GSTO1 4085/4885LMNA 2107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.